Abstract:OBJECTIVE:To investigate the effect of omega-3 polyunsaturated fatty acids (PUFA) on postoperative inflammatory response and clinical efficacy in gastric cancer patients with nutritional risk.METHODS:All patients with gastric cancer in our department from June 2013 to January 2014 undergoing radical gastrectomy were prospectively enrolled in the study. Patients who matched the selection criteria were randomly divided into two groups: trial group (with omega-3 PUFA in parenteral nutrition) and control group (without omega-3 PUFA in parenteral nutrition). Levels of inflammatory factors (serum CRP, TNF-α, IL-1, IL-6, IL-10) and nutrition-related proteins (prealbumin, retinol conjugated protein and transferrin) were compared between the two groups before operation and 2, 4 and 6 days after operation. Incidence of postoperative systemic inflammatory response syndrome (SIRS) and other indicators associated with efficacy were compared between the two groups as well.RESULTS:Forty-seven patients were finally included in this study with 21 patients in the trial group and other 26 in the control group. There were no significant differences of inflammatory factors and nutrition-related proteins between the two groups before operation (all P>0.05). In the 6th days after operation, the levels of proinflammatory cytokines, including CRP, IL-1 and IL-6 were significantly lower in the trial group as compared to the control group, while the level of IL-10 (inhibiting inflammatory cytokine) was higher in the trial group, as well as levels of nutrition proteins(all P<0.05). The trial group had significantly lower rate of SIRS than the control group [57.1%(12/21) vs. 84.6% (22/26), P=0.036]. Compared with the control group, patients in the trial group had shorter bowel sound recovery time [(12.3±1.1) d vs. (3.1±1.3) d, P=0.025], earlier passage of flatus [(3.1±1.0) d vs. (3.9±1.2) d, P=0.025] and shorter hospital stay [(9.4±2.1) d vs. (10.9±2.5) d, P=0.038], but there was no difference in postoperative complication rate between the two groups (P=0.678).CONCLUSIONS:Omega-3 PUFA can reduce the release of inflammatory promoters, promote the release of inhibiting inflammatory cytokine IL-10, decrease the incidence of SIRS, improve patients' nutritional state, expedite the recovery of gastrointestinal function and shorten patients' recovery time.

The Addition of ω-3 Fish Oil Fat Emulsion to Parenteral Nutrition Reduces Short-Term Complications after Laparoscopic Surgery for Gastric Cancer

An Observational Study of the Effects of Ω-3 Polyunsaturated Fatty Acid-Supplemented Parenteral Nutrition on Postoperative Complications in Patients with Crohn's Disease.

Effects of different postoperative nutritional support on oxidative stress and clinical outcomes for patients after gastrointestinal surgery

A prospective, randomized, controlled study of ω-3 fish oil fat emulsion-based parenteral nutrition for patients following surgical resection of gastric tumors

Impact of lipid emulsion containing fish oil on outcomes of surgical patients: systematic review of randomized controlled trials from Europe and Asia.

Safety and efficacy of fish oil-enriched parenteral nutrition regimen on postoperative patients undergoing major abdominal surgery: a meta-analysis of randomized controlled trials.

Fish Oil-Supplemented Parenteral Nutrition in Patients Following Esophageal Cancer Surgery: Effect on Inflammation and Immune Function.

Effect of postoperative early ω-3 polyunsaturated fatty acid-based total parenteral nutrition on postoperative complications for patients with Crohn′s disease

[Effects of Omega-3 Polyunsaturated Fatty Acids on Postoperative Inflammatory Reaction and Clinical Efficacy].

Perioperative use of enteral nutrition with ω-3 polyunsaturated fatty acid in patients with gastric cancer: a meta-analysis

Effect of ω-3 polyunsaturated fatty acids on coagulation and peristalsis in postoperative patients with gastric carcinoma

The Value of Parenteral Fish Oil Lipid Emulsion Supplementation in Patients after Surgical Operation of Hepatobiliary Malignancy

Impact of Short-Term Omega-3 Fatty Acids Supplementation on Clinical Outcomes in Postoperative Patients with Parenteral Nutrition Support: a Meta-analysis of Randomized Controlled Trials

Does Intravenous Fish Oil Benefit Patients Post-Surgery? A Meta-Analysis of Randomised Controlled Trials

Perioperative Ω-3 Polyunsaturated Fatty Acid Nutritional Support in Gastrointestinal Cancer Surgical Patients: A Systematic Evaluation.

The Impact of Fish Oil (Ω-3 Fatty Acids) Intervention on Infectious Complications and Cost-Effectiveness for Postoperative Patients: Systematic Review (2010-2016)

Therapeutic Effect of Ω-3 Fatty Acids on Patients after Surgical Operation of Gastrointestinal Malignancy

Fish Oil for Immunity of Patients with Postoperative Gastrointestinal Cancer:A Meta-analysis

Perioperative omega-3 fatty acids for liver surgery: A meta-analysis of randomized controlled trials

Effect of Ω-3 Polyunsaturated Fatty Acid on Promoting the Postoperative Rehabilitation of Patients with Gastrointestinal Malignancies

The Effect of Ω-3 Fish Oil on Immunologic Function and Inflammatory Reaction of Patients with Gastrointestinal Tumor after Operation